Fakulti Perubatan, Universiti Kebangsaan Malaysia
Cheras, Kuala Lumpur, Malaysia
NCT Number: NCT07397299
This randomized controlled trial aims to determine whether access to a mental health app improves resilience and reduces depressive symptoms among medical students over a three-month period.
Compared to the control group, researchers hypothesized that medical students in the intervention group are expected to show:
* Significant reductions in depressive symptoms and greater improvements in resilience after three months of usage. * Significant reduction in thoughts of self-harm and anxiety, and improvement in self-esteem after three months of usage.
Researchers will compare two groups to evaluate the app's impact on wellbeing:
* Intervention group: Receives immediate full access to the mental health app. * Control group: Receives basic, without full access to the mental health app.
Participants will explore and experience the various features offered in the mental health app over a three-month period.
Trial opening soon.
Get Notified18 year–30 year
All sexes
Interventional
Not applicable
Cheras, Kuala Lumpur, Malaysia
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Name of the mental health app - Intellect: Create A Better You
Name of mental health app - Intellect: Create a Better You
Time frame: Baseline and 3 months
Depressive symptoms will be assessed using the Patient Health Questionnaire-9, developed by Kroenke et al. (2001). This 9-item instrument assesses the frequency of depressive symptoms over the past two weeks. Each item is rated on a 4-point scale, yielding a total severity score ranging from 0 to 27, with higher scores indicating greater severity of depressive symptoms.
Time frame: Baseline and 3 months
Resilience will be measured using the Brief Resilience Scale developed by Smith et al. (2008). This 6-item instrument assesses the ability to recover from stress. Each item is rated on a 5-point Likert scale, yielding a total score ranging from 6 to 30, with higher scores indicating greater resilience.
Time frame: Baseline and 3 months
Anxiety will be assessed using the Generalized Anxiety Disorder-7 developed by Spitzer et al. (2006). This 7-item instrument assesses generalized anxiety symptoms over the past two weeks. Each item is rated on a 4-point scale, resulting in a total severity score ranging from 0 to 21, with higher total score indicating a greater level of anxiety.
Time frame: Baseline and 3 months
Self-esteem will be measured using the Rosenberg Self-Esteem Scale developed by Rosenberg (1989). This 10-item instrument assesses global self-worth by measuring both positive and negative feelings about the self. Each item is rated on a 4-point Likert scale, yielding a total score ranging from 0 to 30, with higher scores indicating more positive self-esteem.
Time frame: Baseline and 3 months
Subjective wellbeing will be measured using the World Health Organization-Five Well-Being Index. This 5-item instrument assesses the respondent's mental wellbeing over the past two weeks. Each item is rated on a 6-point scale. The raw score is typically multiplied by four to get a percentage score ranging from 0 to 100, with higher scores indicating better mental wellbeing.
National University of Malaysia
Other
Evaluating The Impact of A Mental Health App on Depression and Resilience Among Medical Students: A Randomized Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07452900
Anxiety, Anxiety Disorders
Waco, Texas, United States
View Trial DetailsNCT07553364
Behavior, Behavioral Symptoms
Winston-Salem, North Carolina, United States
View Trial DetailsNCT07684521
Anxiety, Anxiety Disorders
Los Angeles, California, United States
View Trial DetailsNCT07664540
Behavior, Behavioral Symptoms
Zurich, Canton of Zurich, Switzerland
View Trial Details